NaiVec Expands Global Market for Peptide Active Pharmaceutical Ingredients Including Obesity Treatments

Naivek, a peptide fusion bio-specialized company, announced on the 4th that it will participate in the "World Pharmaceutical & Bio Expo (CPHI)" held in Milan, Italy. Through this, Naivek plans to accelerate its entry into the global market for its proprietary peptide active pharmaceutical ingredients.

At this CPHI, Naivek will operate an independent booth related to peptide active pharmaceutical ingredients and plans to strengthen global partnering. The company will focus on introducing its research achievements, technical strengths, and production capabilities related to peptide active pharmaceutical ingredients to global pharmaceutical companies.

Naivek has peptide technology capable of responding to various market demands through continuous research and development, enabling active support for the advanced drug development of global pharmaceutical companies. The company explained that it can produce high-quality peptides through a strict quality control system and apply peptide technology in various fields such as anticancer drugs, obesity treatments, and vaccines.

Naivek has obtained the "Good Manufacturing Practice (GMP)" certification for its peptide active pharmaceutical ingredient production facilities from the Ministry of Food and Drug Safety (MFDS). Currently, it produces peptide active pharmaceutical ingredients for some global pharmaceutical companies and formulations applying its self-developed drug delivery system. In addition, it is in discussions with several global companies for the production of peptide-based active pharmaceutical ingredients.

A Naivek representative said, "This year's CPHI, with participation from over 2,400 companies from more than 160 countries worldwide, will be an important opportunity to showcase the company's business capabilities in peptide active pharmaceutical ingredients and strengthen partnerships," adding, "Through this exhibition, we will discover new business opportunities and further expand the global market."

He continued, "Since obesity treatments are based on peptide ingredients, there is great interest in companies with advanced peptide technology in the global market," emphasizing, "At this exhibition, meetings with global pharmaceutical companies regarding long-acting formulations of obesity treatments are also scheduled."

CPHI is an international exhibition held annually where pharmaceutical and bio industry stakeholders from around the world gather to showcase the latest technologies and products. It is a venue to discuss innovations across the pharmaceutical industry, including active pharmaceutical ingredients (API), finished dosage products (FDP), formulations, and packaging. This year, it will be held in Milan, Italy, from the 8th to the 10th of this month.

This content was produced with the assistance of AI translation services.